0001567892-22-000006.txt : 20220315 0001567892-22-000006.hdr.sgml : 20220315 20220315063906 ACCESSION NUMBER: 0001567892-22-000006 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220315 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 22739014 BUSINESS ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 BUSINESS PHONE: 353 1 6960000 MAIL ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 8-K 1 mnk-20220315.htm 8-K mnk-20220315
0001567892false00015678922022-03-152022-03-1500015678922021-03-102021-03-10


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): March 15, 2022
 
Mallinckrodt plc
(Exact name of registrant as specified in its charter)
Ireland001-3580398-1088325
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
 Identification No.)
College Business & Technology Park, Cruiserath,
Blanchardstown, Dublin 15, Ireland
(Address of principal executive offices) (Zip Code)
 
Registrant's telephone number, including area code:  +353 1 696 0000

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act: 
(Title of each class)
Ordinary shares, par value $0.20 per share
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐



Item 2.02    Results of Operations and Financial Condition.
On March 15, 2022, Mallinckrodt plc (the "Company" or "Mallinckrodt") provided its financial results for the quarter and year ended December 31, 2021 in the attached Exhibit 99.1.
The information in this Current Report on Form 8-K, including Exhibit 99.1, should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as otherwise expressly set forth by specific reference in such a filing.
NON-GAAP FINANCIAL MEASURES
Exhibit 99.1 contains financial measures, including adjusted EBITDA and net sales growth on a constant-currency basis, which are considered "non-GAAP" financial measures under applicable U.S. Securities and Exchange Commission rules and regulations.
Adjusted EBITDA represents amounts prepared in accordance with accounting principles generally accepted in the U.S. (GAAP) and adjusts for certain items that management believes are not reflective of the operational performance of the business. Consolidated adjusted EBITDA represents net income (loss), adjusted for interest expense, net, taxes, depreciation and amortization and certain items that management believes are not reflective of the operational performance of the business and additional adjustments. These adjustments include, but are not limited to, restructuring charges, net; non-restructuring impairment charges; discontinued operations; changes in fair value of contingent consideration obligations; significant legal and environmental charges; divestitures; separation costs; unrealized gain on equity investment; research & development upfront payments; reorganization items, net; share-based compensation and other items identified by the Company.
Segment net sales growth on a constant-currency basis measures the change in segment net sales between current- and prior-year periods using a constant currency, the exchange rate in effect during the applicable prior-year period.
The Company has provided these adjusted financial measures because they are used by management, along with financial measures in accordance with GAAP, to evaluate the company's operating performance. In addition, the Company believes that they will be used by certain investors to measure Mallinckrodt's operating results. Management believes that presenting these adjusted measures provides useful information about the Company's performance across reporting periods on a consistent basis by excluding items that the Company does not believe are indicative of its core operating performance. Reconciliations of these financial measures to the most directly comparable GAAP financial measures are included in Exhibit 99.1.
These adjusted measures should be considered supplemental to and not a substitute for financial information prepared in accordance with GAAP.

Item 9.01    Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Exhibit
99.1
104Cover Page Interactive Data File (embedded within the inline XBRL document).



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MALLINCKRODT PLC
(registrant)
Date:March 15, 2022By: /s/ Bryan M. Reasons
Bryan M. Reasons
Executive Vice President and Chief Financial Officer
(principal financial and accounting officer)



 EX-99.1 2 mnk991q42021er.htm EX-99.1 Document

Exhibit 99.1

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in millions, except per share data)
Three Months Ended 1
December 31,
2021		Percent of
Net sales		December 25,
2020		Percent of
Net sales
Net sales
$597.2 100.0 %$682.8 100.0 %
Cost of sales358.7 60.1 372.3 54.5 
Gross profit238.5 39.9 310.5 45.5 
Selling, general and administrative expenses173.5 29.1 200.9 29.4 
Research and development expenses38.9 6.5 65.0 9.5 
Restructuring charges, net9.4 1.6 21.7 3.2 
Non-restructuring impairment charges90.4 15.1 — — 
Gains on divestiture— — (6.5)(1.0)
Opioid-related litigation settlement gain— — (9.3)(1.4)
Operating (loss) income(73.7)(12.3)38.7 5.7 
Interest expense(61.9)(10.4)(60.2)(8.8)
Interest income— — 0.5 0.1 
Other income, net6.1 1.0 6.3 0.9 
Reorganization items, net(99.0)(16.6)(61.4)(9.0)
Loss from continuing operations before income taxes(228.5)(38.3)(76.1)(11.1)
Income tax (benefit) expense(24.4)(4.1)78.1 11.4 
Loss from continuing operations(204.1)(34.2)(154.2)(22.6)
Income from discontinued operations, net of income taxes0.1 — 1.3 0.2 
Net loss$(204.0)(34.2)%$(152.9)(22.4)%
Basic loss per share:
Loss from continuing operations$(2.41)$(1.82)
Income from discontinued operations— 0.02 
Net loss$(2.41)$(1.81)
Diluted loss per share:
Loss from continuing operations$(2.41)$(1.82)
Income from discontinued operations— 0.02 
Net loss$(2.41)$(1.81)
Weighted-average number of shares outstanding
Basic weighted-average shares outstanding84.784.6
Diluted weighted-average shares outstanding84.784.6
(1)The Company reports its results based on a "52-53 week" year ending on the last Friday of December. The three months ended December 31, 2021 refers to the fourteen week period ended December 31, 2021 and the three months ended December 25, 2020 refers to the thirteen week period ended December 25, 2020.



1

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
CONSOLIDATED ADJUSTED EBITDA
(unaudited, in millions)
Three Months Ended
December 31, 2021December 25, 2020
Gross ProfitSG&AR&DAdjusted EBITDAGross ProfitSG&AR&DAdjusted EBITDA
Net loss$238.5 $173.5 $38.9 $(204.0)$310.5 $200.9 $65.0 $(152.9)
Adjustments:
Interest expense, net— — — 61.9 — — — 59.7 
Income taxes— — — (24.4)— — — 78.1 
Depreciation(1)
18.1 (4.2)(2.1)24.4 17.7 (18.8)(1.8)38.3 
Amortization144.4 (0.9)— 145.3 170.6 (0.8)— 171.4 
Restructuring charges, net— — — 9.4 — — — 21.7 
Non-restructuring impairment charge— — — 90.4 — — — — 
Income from discontinued operations— — — (0.1)— — — (1.3)
Change in contingent consideration fair value— (0.2)— 0.2 — (7.5)— 7.5 
Significant legal and environmental charges (2)
— (34.3)— 34.3 0.9 (2.6)— (5.8)
Gains on divestiture— — — — — — — (6.5)
Separation costs— (0.2)— 0.2 — (18.4)— 18.4 
Unrealized gain on equity investment— — — 0.1 — — — (1.6)
Reorganization items, net— — — 99.0 — — — 61.4 
Share-based compensation 0.1 (1.5)(0.2)1.8 0.4 (6.0)(1.3)7.7 
Japanese consumption tax credit— — — (6.8)— — — — 
As adjusted:$401.1 $132.2 $36.6 $231.7 $500.1 $146.8 $61.9 $296.1 
(1)Includes $0.1 million and $12.3 million of accelerated depreciation in selling general and administrative expenses ("SG&A") related to restructuring charges incurred during the three months ended December 31, 2021 and December 25, 2020, respectively.
(2)Represents an increase in environmental liabilities during the three months ended December 31, 2021. The three months ended December 25, 2020 includes a $9.3 million decrease in the fair value of the opioid settlement warrants, partially offset by $2.6 million in opioid defense costs and a $0.9 million change to the retrospective Medicaid lawsuit liability.



2

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
SEGMENT OPERATING INCOME
(unaudited, in millions)
Three Months Ended
December 31,
2021		December 25,
2020
Specialty Brands$224.2 $250.7 
Specialty Generics34.1 50.9 
Segment operating income258.3 301.6 
Unallocated amounts:
Corporate and unallocated expenses (1)
(60.5)(13.8)
Depreciation and amortization(169.7)(209.7)
Share-based compensation(1.8)(7.7)
Restructuring charges, net(9.4)(21.7)
Non-restructuring impairment charges(90.4)— 
Separation costs(0.2)(18.4)
Opioid-related litigation settlement gain— 9.3 
Medicaid lawsuit— (0.9)
Operating (loss) income$(73.7)$38.7 
(1)Includes administration expenses and certain compensation, legal, environmental and other costs not charged to the Company's reportable segments.
3

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
SEGMENT NET SALES AND CONSTANT-CURRENCY GROWTH
(unaudited, in millions)
Three Months Ended
December 31,
2021		December 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands$397.4 $506.6 (21.6)%(0.1)%(21.5)%
Specialty Generics199.8 177.1 12.8 0.1 12.7 
Segment net sales597.2 683.7 (12.7)(0.1)(12.6)
Medicaid lawsuit— (0.9)***
Net sales$597.2 $682.8 (12.5)%(0.1)%(12.4)%
*Not meaningful
MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
SELECT PRODUCT LINE NET SALES AND CONSTANT-CURRENCY GROWTH
(unaudited, in millions)
Three Months Ended
December 31,
2021		December 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands
Acthar Gel$169.7 $191.3 (11.3)%— %(11.3)%
INOmax110.2 135.6 (18.7)— (18.7)
Ofirmev4.9 60.5 (91.9)— (91.9)
Therakos68.7 64.5 6.5 (0.9)7.4 
Amitiza41.1 50.6 (18.8)— (18.8)
Other2.8 4.1 (31.7)— (31.7)
Specialty Brands Total397.4 506.6 (21.6)(0.1)(21.5)
Specialty Generics
Hydrocodone (API) and hydrocodone-containing tablets22.0 26.1 (15.7)— (15.7)
Oxycodone (API) and oxycodone-containing tablets19.0 20.4 (6.9)— (6.9)
Acetaminophen (API)69.1 58.5 18.1 — 18.1 
Other controlled substances84.8 66.1 28.3 0.2 28.1 
Other4.9 6.0 (18.3)— (18.3)
Specialty Generics Total199.8 177.1 12.8 0.1 12.7 
Segment net sales597.2 683.7 (12.7)(0.1)(12.6)
Medicaid lawsuit— (0.9)***
Net sales$597.2 $682.8 (12.5)%(0.1)%(12.4)%
*Not meaningful



4

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in millions, except per share data)
Fiscal Year 1
December 31,
2021		Percent of
Net sales		December 25,
2020		Percent of
Net sales
Net sales (includes refined estimate of the retrospective one-time charge of $536.0 related to the Medicaid lawsuit for the fiscal year ended December 25, 2020)
$2,208.8 100.0 %$2,213.4 100.0 %
Cost of sales1,317.1 59.6 1,544.0 69.8 
Gross profit891.7 40.4 669.4 30.2 
Selling, general and administrative expenses581.8 26.3 884.1 39.9 
Research and development expenses205.2 9.3 290.8 13.1 
Restructuring charges, net26.9 1.2 37.5 1.7 
Non-restructuring impairment charges154.9 7.0 63.5 2.9 
Losses (gains) on divestiture0.8 — (16.6)(0.7)
Opioid-related litigation settlement loss (gain)125.0 5.7 (43.4)(2.0)
Medicaid lawsuit— — 105.1 4.7 
Operating loss(202.9)(9.2)(651.6)(29.4)
Interest expense(222.6)(10.1)(261.1)(11.8)
Interest income1.9 0.1 5.9 0.3 
Other income, net22.0 1.0 7.4 0.3 
Reorganization items, net(428.2)(19.4)(61.4)(2.8)
Loss from continuing operations before income taxes
(829.8)(37.6)(960.8)(43.4)
Income tax (benefit) expense(106.3)(4.8)8.9 0.4 
Loss from continuing operations(723.5)(32.8)(969.7)(43.8)
Income from discontinued operations, net of income taxes
6.1 0.3 25.1 1.1 
Net loss$(717.4)(32.5)%$(944.6)(42.7)%
Basic loss per share:
Loss from continuing operations$(8.54)$(11.48)
Income from discontinued operations0.07 0.30 
Net loss$(8.47)$(11.18)
Diluted loss per share:
Loss from continuing operations$(8.54)$(11.48)
Income from discontinued operations0.07 0.30 
Net loss$(8.47)$(11.18)
Weighted-average number of shares outstanding:
Basic84.784.5
Diluted84.784.5
(1)The Company reports its results based on a "52-53 week" year ending on the last Friday of December. Fiscal 2021 consisted of 53 weeks and fiscal 2020 consisted of 52 weeks.
5

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
CONSOLIDATED ADJUSTED EBITDA
(unaudited, in millions)
Fiscal Year
December 31, 2021December 25, 2020
Gross ProfitSG&AR&DAdjusted EBITDAGross ProfitSG&AR&DAdjusted EBITDA
Net loss$891.7 $581.8 $205.2 $(717.4)$669.4 $884.1 $290.8 $(944.6)
Adjustments:
Interest expense, net— — — 220.7 — — — 255.2 
Income taxes— — — (106.3)— — — 8.9 
Depreciation(1)
70.3 (17.6)(6.8)94.7 71.9 (35.1)(7.0)114.0 
Amortization577.7 (3.4)— 581.1 767.8 (3.4)— 771.2 
Restructuring charges, net— — — 26.9 — — — 37.5 
Non-restructuring impairment charge— — — 154.9 — — — 63.5 
Income from discontinued operations— — — (6.1)— — — (25.1)
Change in contingent consideration fair value— 7.4 — (7.4)— (9.9)— 9.9 
Significant legal and environmental charges (2)
— (34.3)— 159.3 536.0 (55.7)— 653.4 
Losses (gains) on divestiture— — — 0.8 — — — (16.6)
Separation costs— (1.2)— 1.2 — (93.4)— 93.4 
Unrealized gain on equity investment— — — (4.7)— — — (3.8)
R&D upfront payment— — — — — — (5.0)5.0 
Reorganization items, net— — — 428.2 — — — 61.4 
Share-based compensation0.5 (8.1)(1.6)10.2 1.3 (19.9)(4.1)25.3 
Japanese consumption tax credit— — — (6.8)— — — — 
As adjusted:$1,540.2 $524.6 $196.8 $829.3 $2,046.4 $666.7 $274.7 $1,108.6 
(1)Includes $2.1 million and $12.3 million of accelerated depreciation in SG&A related to restructuring charges incurred during fiscal 2021 and 2020, respectively.
(2)Fiscal 2021 includes a $125.0 million charge related to the opioid-related litigation settlement liability and a $34.3 million increase in environmental liabilities. Fiscal 2020 includes a retrospective one-time charge of $641.1 million (the "Acthar Gel Medicaid Retrospective Rebate"), of which $536.0 million and $105.1 million have been reflected as a component of net sales and operating expenses, respectively, in the condensed consolidated statement of operations. The $105.1 million reflected as a component of operating expenses represents a pre-acquisition contingency related to the portion of the Acthar Gel Medicaid Retrospective Rebate that arose from sales of Acthar Gel prior to the Company’s acquisition of Questcor Pharmaceuticals, Inc. in August 2014. Fiscal 2020 also includes $55.7 million of opioid defense costs, partially offset by a $43.4 million decrease in the fair value of the opioid settlement warrants.

6

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
SEGMENT OPERATING INCOME
(unaudited, in millions)
Fiscal Year
December 31,
2021		December 25,
2020
Specialty Brands$812.8 $1,015.7 
Specialty Generics107.9 206.4 
Segment operating income920.7 1,222.1 
Unallocated amounts:
Corporate and unallocated expenses (1)
(129.6)(166.1)
Depreciation and amortization(675.8)(885.2)
Share-based compensation(10.2)(25.3)
Restructuring charges, net(26.9)(37.5)
Non-restructuring impairment charges(154.9)(63.5)
Separation costs(1.2)(93.4)
R&D upfront payment— (5.0)
Opioid-related litigation settlement (loss) gain(125.0)43.4 
Medicaid lawsuit— (641.1)
Operating loss$(202.9)$(651.6)
(1)Includes administration expenses and certain compensation, legal, environmental and other costs not charged to the Company's reportable segments.

7

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
SEGMENT NET SALES AND CONSTANT-CURRENCY GROWTH
(unaudited, in millions)
Fiscal Year
December 31,
2021		December 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands$1,547.0 $2,059.6 (24.9)%0.2 %(25.1)%
Specialty Generics661.8 689.8 (4.1)0.1 (4.2)
Segment net sales2,208.8 2,749.4 (19.7)0.2 (19.9)
Medicaid lawsuit— (536.0)***
Net sales$2,208.8 $2,213.4 (0.2)%0.2 %(0.4)%
*Not meaningful
MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
SELECT PRODUCT LINE NET SALES
(unaudited, in millions)
Fiscal Year
December 31,
2021		December 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands
Acthar$593.6 $767.9 (22.7)%— %(22.7)%
INOmax448.5 574.1 (21.9)0.1 (22.0)
Ofirmev28.9 276.5 (89.5)— (89.5)
Therakos266.5 238.6 11.7 1.3 10.4 
Amitiza196.9 188.8 4.3 — 4.3 
Other12.6 13.7 (8.0)— (8.0)
Specialty Brands Total1,547.0 2,059.6 (24.9)0.2 (25.1)
Specialty Generics
Hydrocodone (API) and hydrocodone-containing tablets82.7 98.0 (15.6)— (15.6)
Oxycodone (API) and oxycodone-containing tablets68.5 68.4 0.1 — 0.1 
Acetaminophen (API)215.9 213.0 1.4 — 1.4 
Other controlled substances272.7 289.9 (5.9)0.3 (6.2)
Other22.0 20.5 7.3 — 7.3 
Specialty Generics Total661.8 689.8 (4.1)0.1 (4.2)
Segment net sales2,208.8 2,749.4 (19.7)0.2 (19.9)
Medicaid lawsuit— (536.0)***
Net sales$2,208.8 $2,213.4 (0.2)%0.2 %(0.4)%
*Not meaningful
8

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in millions)
December 31,
2021		December 25,
2020
Assets
Current Assets:
Cash and cash equivalents$1,345.0 $1,070.6 
Accounts receivable, net439.1 538.8 
Inventories347.2 344.9 
Prepaid expenses and other current assets178.3 350.0 
Total current assets2,309.6 2,304.3 
Property, plant and equipment, net776.0 833.1 
Intangible assets, net5,448.4 6,184.5 
Other assets382.3 393.5 
Total Assets$8,916.3 $9,715.4 
Liabilities and Shareholders' Equity
Current Liabilities:
Current maturities of long-term debt$1,388.9 $3,587.9 
Accounts payable123.0 93.3 
Accrued payroll and payroll-related costs84.6 79.4 
Accrued interest17.0 26.9 
Accrued and other current liabilities328.7 331.2 
Total current liabilities1,942.2 4,118.7 
Pension and postretirement benefits30.1 34.6 
Environmental liabilities43.0 59.8 
Deferred income taxes20.9 80.6 
Other income tax liabilities83.2 100.1 
Other liabilities85.8 109.8 
Liabilities subject to compromise6,397.7 4,192.6 
Total Liabilities8,602.9 8,696.2 
Shareholders' Equity:
Preferred shares— — 
Ordinary shares
18.9 18.8 
Ordinary shares held in treasury at cost(1,616.1)(1,616.1)
Additional paid-in capital5,597.8 5,587.6 
Retained deficit(3,678.9)(2,961.5)
Accumulated other comprehensive loss(8.3)(9.6)
Total Shareholders' Equity313.4 1,019.2 
Total Liabilities and Shareholders' Equity$8,916.3 $9,715.4 


9

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
(IN EXAMINATION UNDER PART 10 OF THE IRISH COMPANIES ACT 2014)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in millions)
Fiscal Year
December 31,
2021		December 25,
2020
Cash Flows From Operating Activities:
Net loss$(717.4)$(944.6)
Adjustments to reconcile net cash from operating activities:
Depreciation and amortization675.8 885.2 
Share-based compensation10.2 25.3 
Deferred income taxes(59.9)385.3 
Non-cash impairment charges154.9 63.5 
Inventory provisions11.5 18.5 
Losses (gains) on divestiture0.8 (16.6)
Other non-cash items(13.1)(40.2)
Reorganization items, net22.5 10.2 
Changes in assets and liabilities:
Accounts receivable, net98.2 37.9 
Inventories(14.0)(51.1)
Accounts payable(1.1)15.7 
Income taxes108.5 (433.8)
Opioid-related litigation settlement liability125.0 — 
Medicaid lawsuit(4.2)638.9 
Other57.7 (95.3)
Net cash from operating activities455.4 498.9 
Cash Flows From Investing Activities:
Capital expenditures(55.3)(47.7)
Proceeds (payments) related to divestiture, net of cash15.7 (0.7)
Other1.8 37.2 
Net cash from investing activities(37.8)(11.2)
Cash Flows From Financing Activities:
Repayment of external debt(137.5)(139.5)
Debt financing costs— (9.4)
Repurchase of shares— (0.4)
Other— (36.3)
Net cash from financing activities(137.5)(185.6)
Effect of currency rate changes on cash(1.9)2.3 
Net change in cash, cash equivalents and restricted cash278.2 304.4 
Cash, cash equivalents and restricted cash at beginning of period1,127.0 822.6 
Cash, cash equivalents and restricted cash at end of period$1,405.2 $1,127.0 
Cash and cash equivalents at end of period$1,345.0 $1,070.6 
Restricted cash included in prepaid expenses and other assets at end of period24.0 20.2 
Restricted cash included in other long-term assets at end of period36.2 36.2 
Cash, cash equivalents and restricted cash at end of period$1,405.2 $1,127.0 
10
 EX-101.SCH 3 mnk-20220315.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mnk-20220315_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material City Area Code City Area Code Document Type Document Type Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Address, Country Entity Address, Country Document Period End Date Document Period End Date Country Region Country Region Entity Address, City or Town Entity Address, City or Town Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(g) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code EX-101.PRE 5 mnk-20220315_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information Document
Mar. 15, 2022
Mar. 10, 2021
Document and Entity Information [Abstract]    
Entity Central Index Key 0001567892  
Title of 12(b) Security   Ordinary shares, par value $0.20 per share
Written Communications false  
Entity Incorporation, State or Country Code L2  
Document Type 8-K  
Document Period End Date Mar. 15, 2022  
Entity Registrant Name Mallinckrodt plc  
Entity File Number 001-35803  
Entity Tax Identification Number 98-1088325  
Entity Address, Address Line One College Business & Technology Park  
Entity Address, City or Town Dublin  
Entity Address, Postal Zip Code 15  
Entity Address, Country IE  
City Area Code 1  
Local Phone Number 696 0000  
Soliciting Material false  
Pre-commencement Tender Offer false  
Pre-commencement Issuer Tender Offer false  
Entity Emerging Growth Company false  
Amendment Flag false  
Entity Address, Address Line Two Cruiserath  
Entity Address, Address Line Three Blanchardstown  
Country Region 353  
XML 7 mnk-20220315_htm.xml IDEA: XBRL DOCUMENT 0001567892 2022-03-15 2022-03-15 0001567892 2021-03-10 2021-03-10 0001567892 false 8-K 2022-03-15 Mallinckrodt plc L2 001-35803 98-1088325 College Business & Technology Park Cruiserath Blanchardstown Dublin 15 IE 353 1 696 0000 false false false false Ordinary shares, par value $0.20 per share false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 2 123 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports mnk-20220315.htm mnk-20220315.xsd mnk-20220315_lab.xml mnk-20220315_pre.xml mnk991q42021er.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mnk-20220315.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 2, "dts": { "inline": { "local": [ "mnk-20220315.htm" ] }, "labelLink": { "local": [ "mnk-20220315_lab.xml" ] }, "presentationLink": { "local": [ "mnk-20220315_pre.xml" ] }, "schema": { "local": [ "mnk-20220315.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 123, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mnk", "nsuri": "http://www.mallinckrodt.com/20220315", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mnk-20220315.htm", "contextRef": "i14ace20e21b843cc99263c5af8dc8893_D20210310-20210310", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12gTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mnk-20220315.htm", "contextRef": "i14ace20e21b843cc99263c5af8dc8893_D20210310-20210310", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12gTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "mnk_DocumentandEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]", "terseLabel": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentandEntityInformationAbstract", "nsuri": "http://www.mallinckrodt.com/20220315", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001567892-22-000006-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001567892-22-000006-xbrl.zip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end